Error: Could not add to watchlist. X

ThromboGenics NV

+ Watchlist
TG4:GR
Berlin
2.99
EUR
0.09
3.02%
As of 02:13:02 ET on 09/01/2015.
Open
3.00
Day Range
2.89 - 3.00
Volume
33
Previous Close
3.08
52Wk Range
2.80 - 8.64
1 Yr Return
-65.27%
Open
3.00
Day Range
2.89 - 3.00
Volume
33
Previous Close
3.08
52Wk Range
2.80 - 8.64
1 Yr Return
-65.27%
YTD Return
-53.98%
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-
Market Cap (m EUR)
107.814
Shares Outstanding (m)
36.094
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
ThromboGenics NV is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company is focused on developing medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system.
ADDRESS
Gaston Geenslaan 1
B-3001
Heverlee
Belgium
PHONE
32-16-75-13-10
  • Patrik De Haes
    CEO/Executive Director
  • Dominique Vanfleteren
    Chief Financial Officer
  • Claude Sander
    Chief Legal Officer
  • Laurence Raemdonck
    Head:Human Resources
  • Aniz Girach
    Head:Clinical Ophthalmology
Show More